AI
The collaboration aims to foster innovation, commercialization and adoption of AI in imaging.
This marks AITRICS's first foray into Southeast Asia, with applications for regulatory clearance in Indonesia and Malaysia underway.
Cardio Intelligence is now testing its latest AI for detecting paroxysmal atrial fibrillation.
The project aims to promote AI-powered tech support for care providers and help streamline administrative tasks while boosting clinical decision-making.
Peak body RACGP has recently released its guidance for adopting the technology.
It has also received Australia's regulatory approval for its AI solution.
Also, New Zealand's The Doctors has cautioned the public about a mobile app posing as its official app.
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
Cloudphysician targets to enter the United States, the Middle East, and Southeast Asia with its smart ICU and emergency department solutions.
Interestingly, young physicians see more risk to it than their senior counterparts.